Terms: = Ovarian cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Staging
1 results:
1. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
